Walgreens Boots Ownership

WBA Stock  USD 11.25  0.36  3.31%   
Walgreens Boots Alliance retains a total of 864.15 Million outstanding shares. Over half of Walgreens Boots' outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that on October 8, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of Walgreens Boots Alliance's common stock.
 
Shares in Circulation  
First Issued
1985-09-30
Previous Quarter
863.7 M
Current Value
863.8 M
Avarage Shares Outstanding
B
Quarterly Volatility
207 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Walgreens Boots in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Walgreens Boots, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Walgreens Stock Ownership Analysis

About 17.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.98. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Walgreens Boots Alliance recorded a loss per share of 10.24. The entity last dividend was issued on the 18th of November 2024. The firm had 2:1 split on the 16th of February 1999. Walgreens Boots Alliance, Inc. operates as an integrated healthcare, pharmacy, and retailer in the United States , the United Kingdom, Germany, and internationally. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois. Walgreens Boots operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 200000 people. For more information please call Timothy Wentworth at 847 315 3700 or visit https://www.walgreensbootsalliance.com.
Besides selling stocks to institutional investors, Walgreens Boots also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Walgreens Boots' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Walgreens Boots' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Walgreens Boots Quarterly Liabilities And Stockholders Equity

78.54 Billion

Walgreens Boots Insider Trades History

About 17.0% of Walgreens Boots Alliance are currently held by insiders. Unlike Walgreens Boots' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Walgreens Boots' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Walgreens Boots' insider trades
 
Yuan Drop
 
Covid

Walgreens Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Walgreens Boots is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Walgreens Boots Alliance backward and forwards among themselves. Walgreens Boots' institutional investor refers to the entity that pools money to purchase Walgreens Boots' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Norges Bank2024-06-30
6.9 M
Legal & General Group Plc2024-09-30
6.6 M
Barclays Plc2024-09-30
6.3 M
Millennium Management Llc2024-09-30
5.7 M
Susquehanna International Group, Llp2024-09-30
5.5 M
Bank Of New York Mellon Corp2024-09-30
M
Deutsche Bank Ag2024-09-30
4.7 M
Schroder Investment Management Group2024-09-30
4.6 M
Allianz Asset Management Ag2024-09-30
4.3 M
Vanguard Group Inc2024-09-30
84.1 M
Blackrock Inc2024-09-30
70.7 M
Note, although Walgreens Boots' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Walgreens Boots' latest congressional trading

Congressional trading in companies like Walgreens Boots Alliance, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Walgreens Boots by those in governmental positions are based on the same information available to the general public.
2024-10-08Representative Ro KhannaAcquired Under $15KVerify
2024-05-14Senator Tommy TubervilleAcquired $50K to $100KVerify
2024-04-15Senator Tommy TubervilleAcquired $15K to $50KVerify
2024-04-14Senator Tommy TubervilleAcquired $15K to $50KVerify
2024-03-22Representative Michael C BurgessAcquired Under $15KVerify
2023-03-07Representative Tom ColeAcquired $15K to $50KVerify
2019-05-06Representative David B McKinleyAcquired Under $15KVerify
2018-08-15Representative Ed PerlmutterAcquired Under $15KVerify
2018-05-08Representative Peter WelchAcquired Under $15KVerify

Walgreens Boots Outstanding Bonds

Walgreens Boots issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Walgreens Boots Alliance uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Walgreens bonds can be classified according to their maturity, which is the date when Walgreens Boots Alliance has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Walgreens Boots Corporate Filings

24th of January 2025
Other Reports
ViewVerify
8K
10th of January 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
ASR
16th of December 2024
Automatic Shelf Registration Statement under Rule 415 filed with the U.S. Securities and Exchange Commission (SEC)
ViewVerify
13th of December 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Walgreens Boots Alliance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Walgreens Boots' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Walgreens Boots Alliance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Walgreens Boots Alliance Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Walgreens Boots. If investors know Walgreens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Walgreens Boots listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.915
Earnings Share
(10.24)
Revenue Per Share
171.079
Quarterly Revenue Growth
0.06
Return On Assets
0.0059
The market value of Walgreens Boots Alliance is measured differently than its book value, which is the value of Walgreens that is recorded on the company's balance sheet. Investors also form their own opinion of Walgreens Boots' value that differs from its market value or its book value, called intrinsic value, which is Walgreens Boots' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Walgreens Boots' market value can be influenced by many factors that don't directly affect Walgreens Boots' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Walgreens Boots' value and its price as these two are different measures arrived at by different means. Investors typically determine if Walgreens Boots is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Walgreens Boots' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.